Long COVID in Children and Adolescents: Mechanisms, Symptoms, and Long-Term Impact on Health—A Comprehensive Review
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(2), P. 378 - 378
Published: Jan. 9, 2025
Long
COVID,
also
known
as
post-acute
sequelae
of
SARS-CoV-2
infection
(PASC),
is
increasingly
recognized
a
condition
affecting
not
only
adults
but
children
and
adolescents.
While
often
experience
milder
acute
COVID-19
symptoms
compared
to
adults,
some
develop
persistent
physical,
psychological,
neurological
lasting
for
weeks
or
months
after
initial
infection.
The
most
commonly
reported
include
debilitating
fatigue,
respiratory
issues,
headaches,
muscle
pain,
gastrointestinal
disturbances,
cognitive
difficulties,
which
significantly
impact
daily
activities,
schooling,
social
interactions.
Additionally,
many
with
long
COVID
psychological
symptoms,
such
anxiety,
depression,
mood
swings,
irritability,
likely
exacerbated
by
prolonged
illness
lifestyle
disruptions.
Risk
factors
in
pre-existing
health
conditions
asthma,
obesity,
disorders,
adolescents
females
seemingly
more
affected.
Hypothesized
mechanisms
underlying
chronic
immune
dysregulation,
viral
particles
stimulating
inflammation,
autonomic
nervous
system
dysfunction,
mitochondrial
impairment,
may
collectively
contribute
the
variety
observed
symptoms.
Long-term
outcomes
remain
uncertain;
however,
can
lead
school
absenteeism,
withdrawal,
distress,
potentially
development.
Severe
cases
postural
orthostatic
tachycardia
syndrome
(POTS)
reduced
exercise
tolerance.
This
review
synthesizes
existing
literature
on
children,
examining
its
prevalence,
symptomatology,
risk
factors,
potential
mechanisms,
an
emphasis
need
further
clinical
studies.
research
largely
relies
surveys
self-reported
data,
assessments
are
essential
accurately
characterize
pediatric
populations
guide
effective
management
strategies.
Language: Английский
Retrospective Study of the Impact of SARS-CoV-2 Infection on Asthma Control in Children
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(2), P. 356 - 356
Published: Jan. 9, 2025
Asthmatic
children
who
tested
positive
for
COVID-19
experienced
changes
in
lung
function
and
persistent
symptoms
following
SARS-CoV-2
infection,
even
several
months
after
diagnosis,
with
the
same
features
as
an
acute
phase.
This
study
aimed
to
analyze
a
pediatric
age
group
(between
0
17
years
old)
diagnosed
asthma,
infection
attending
regular
monitoring
visits
Pediatric
Department
of
Regional
Tertiary
Hospital
(Filantropia
Clinical
Municipal
Craiova,
Romania)
during
pandemic
post-pandemic
time
interval
(i.e.,
March
2020-July
2024),
identify
how
influenced
their
long-term
treatment.
Materials
Methods.
The
variables
were
recorded:
demographic
data
(gender,
group,
residence),
related
allergies
(allergic
rhinitis,
atopic
dermatitis,
food
allergies),
presence
exacerbations,
fraction
exhaled
nitric
oxide,
ventilatory
function,
asthma
phenotype
or
non-allergic),
well
GINA
assessment
control
at
clinical
analyzed.
infections
evaluated
terms
year
symptoms,
cough
persistence,
modifications
treatment
disease.
statistically
analyzed
SPSS,
using
Mann-Whitney
U,
Kruskal-Wallis
H,
Chi-Square
tests.
Results.
A
lower
incidence
cases
was
recorded
first
asthmatic
patients
(2020
2021),
but
increase
rate
observed
beginning
second
pandemic,
2022.
oxide
values
infected
significantly
increased
(p
<
0.0005),
especially
more
than
4
weeks.
significant
number
exacerbations
also
0.0005).
Ventilatory
different
without
0.05).
Conclusions.
persistence
phase
tests
emphasize
need
periodic
medical
check-ups,
implementation
therapeutic
regimen
appropriate
each
patient.
Language: Английский
Effects of Early-Life Air Pollution Exposure on Childhood COVID-19 Infection and Sequelae in China
Chan Lu,
No information about this author
Wen Deng,
No information about this author
Zipeng Qiao
No information about this author
et al.
Journal of Hazardous Materials,
Journal Year:
2025,
Volume and Issue:
unknown, P. 137940 - 137940
Published: March 1, 2025
Language: Английский
Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection
Life,
Journal Year:
2024,
Volume and Issue:
14(9), P. 1063 - 1063
Published: Aug. 25, 2024
Asthma
is
one
of
the
most
common
chronic
inflammatory
diseases
childhood
with
a
heterogeneous
impact
on
health
and
quality
life.
Mepolizumab
an
antagonist
interleukin-5,
indicated
as
adjunct
therapy
for
severe
refractory
eosinophilic
asthma
in
adolescents
children
aged
>6
years
old.
We
present
case
9
year-old
boy
who
experienced
several
asthmatic
exacerbations
following
SARS-CoV-2
infection,
necessitating
short-acting
bronchodilators,
oral
corticosteroids,
hospitalization.
follow
patient
using
validated
questionnaires
evaluation
control:
Children
Control
Test,
Questionnaire,
respiratory
function
tests,
exhaled
nitric
oxide
fraction.
After
12
weeks
from
start
mepolizumab,
we
found
significant
improvements
lung
function,
reduction
degree
bronchial
inflammation,
No
have
been
reported
since
initiation
treatment
mepolizumab.
Respiratory
infections,
such
those
related
to
SARS-CoV-2,
represent
risk
factor
patients
moderate
forms
asthma.
In
our
experience,
new
episodes
exacerbation,
mepolizumab
has
allowed
us
improve
control
enhance
life
first
doses.
Although
showed
promise
this
child
during
results
single
cannot
be
generalized.
Further
studies
are
needed
confirm
its
safety
effectiveness.
Language: Английский
Lung Ultrasound Efficacy in Monitoring Post-SARS-CoV-2 Pneumonia and Inflammatory Biomarkers in Pediatric Patients
R. Chelcea,
No information about this author
Mihaela Dediu,
No information about this author
Diana Dabica
No information about this author
et al.
Medicina,
Journal Year:
2024,
Volume and Issue:
60(8), P. 1296 - 1296
Published: Aug. 11, 2024
Background
and
Objectives:
Recognizing
the
crucial
gaps
in
our
understanding
of
pediatric
pneumonia
post-SARS-CoV-2
infection,
this
study
aimed
to
assess
relationship
between
Pediatric
Pneumonia
Ultrasound
Scores
(PedPne)
inflammatory
biomarkers.
The
primary
objective
is
evaluate
predictive
value
PedPne
comparison
with
biomarkers
(IL-6
dNLR)
for
development
patients
following
SARS-CoV-2
infection.
Materials
Methods:
This
longitudinal
observational
collected
data
from
diagnosed
after
an
acute
SARS-CoV2
focused
on
analyzing
changes
scores
markers
such
as
IL-6
dNLR
initial
admission
follow-up
at
7
days.
Statistical
analysis
involved
calculating
sensitivity,
specificity,
Area
Under
Curve
(AUC)
each
biomarker,
alongside
regression
determine
their
hazard
ratios
predicting
development.
Results:
identified
significant
cutoff
values
1.88
(sensitivity
77.0%,
specificity
85.7%,
AUC
0.802,
p
<
0.001),
6.1
pg/mL
70.3%,
92.9%,
0.869,
score
3.3
75.7%,
78.6%,
0.794,
0.001).
Conversely,
NLR
showed
lower
diagnostic
performance
(AUC
0.485,
=
0.327).
Regression
further
highlighted
strong
power
these
markers,
showing
a
fourfold
increase
risk
(HR
4.25,
CI:
2.07–9.53,
indicating
more
than
twofold
2.53,
1.19–6.97,
0.006),
associated
doubling
2.60,
1.33–5.18,
Conclusions:
conclusively
demonstrated
that
both
ultrasound
specific
are
predictors
post-COVID-19
These
findings
advocate
integration
routine
clinical
assessments
enhance
accuracy
management
children
Language: Английский
Role of Lung Ultrasound in the Detection of Lung Sequelae in Post-COVID-19 Patients: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(18), P. 5607 - 5607
Published: Sept. 21, 2024
Background:
During
the
COVID-19
pandemic,
several
studies
demonstrated
effectiveness
of
lung
ultrasound
(LUS)
as
a
frontline
tool
in
diagnosing
and
managing
acute
SARS-CoV-2
pneumonia.
However,
its
role
detecting
post-COVID-19
sequelae
remains
to
be
fully
determined.
This
study
aims
evaluate
diagnostic
accuracy
LUS
identifying
parenchymal
damage,
particularly
fibrotic-like
changes,
following
pneumonia,
comparing
performance
that
CT.
Methods:
Relevant
published
before
July
2024
were
identified
through
comprehensive
search
PubMed,
Embase,
Cochrane
library.
The
terms
combinations
relevant
medical
subject
heading
(MeSH)
terms,
key
words
word
variants
for
“lung”,
“post-COVID”,
“long-COVID”,
“ultrasound”.
pooled
sensitivity,
specificity,
odds
ratio
(DOR),
summary
receiver-operating
characteristic
(SROC)
curve
used
examine
CEUS.
selected
works
different
thresholds
detection
counting
B-lines
by
ultrasound.
led
dividing
our
analysis
into
two
models,
first
based
on
lower
found
works,
second
data
obtained
using
higher
threshold.
Results:
In
residual
changes
patients
infection,
low-threshold
model
displayed
sensitivity
0.98
[95%
confidence
interval
(CI):
0.95–0.99]
specificity
0.54
(95%
CI:
0.49–0.59).
DOR
was
44.9
10.8–187.1).
area
under
(AUC)
SROC
0.90.
analysis,
with
threshold
detect
showed
0.90
0.85–0.94)
0.88
0.84–0.91).
50.4
15.9–159.3).
AUC
0.93.
Conclusions:
both
analyses
(even
high
B-lines),
excellent
(98%
1
90%
2)
is
maintained.
has
significant
variation
between
models
from
54
(model
1)
87%
2).
highest
best
accuracy,
confirmed
values
(0.93).
Language: Английский